Obesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications

Valeria Simone; Morena D’Avenia; Antonella Argentiero; Claudia Felici; Francesca Maria Rizzo; Giovanni De Pergola; Franco Silvestris

doi:10.1634/theoncologist.2015-0351

journal article Feb 10, 2016

Obesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications

Valeria Simone Morena D’Avenia Antonella Argentiero Claudia Felici Francesca Maria Rizzo Giovanni De Pergola Franco Silvestris

The Oncologist Vol. 21 No. 4 pp. 404-417 · Oxford University Press (OUP)

View at Publisher Save 10.1634/theoncologist.2015-0351

Abstract

Abstract
Obesity is an important risk factor for breast cancer (BC) in postmenopausal women; interlinked molecular mechanisms might be involved in the pathogenesis. Increased levels of estrogens due to aromatization of the adipose tissue, inflammatory cytokines such as tumor necrosis factor-α, interleukin-6, and prostaglandin E2, insulin resistance and hyperactivation of insulin-like growth factors pathways, adipokines, and oxidative stress are all abnormally regulated in obese women and contribute to cancerogenesis. These molecular factors interfere with intracellular signaling in the mitogen-activated protein kinase and phosphatydilinositol-3-phosphate/mammalian target of rapamycin (mTOR) pathways, which regulate the progression of the cell cycle, apoptosis, and protein synthesis. In this context, structural defects of typical genes related to both BC and obesity, such as leptin, leptin receptor, serum paraoxonase/arylesterase 1, the fat mass and obesity-associated gene and melanocortin receptor 4, have been associated with a high or low risk of BC development. The early detection of these gene alterations might be useful as risk predictors in obese women, and targeting these pathways involved in the BC pathogenesis in obese women is a potential therapeutic tool. In particular, mTOR pathway deregulation concurs in both obesity and BC, and inhibition of this might disrupt the molecular interlinks in a similar manner to that of metformin, which exerts definite anticancer activity and is currently used as an antidiabetic drug with a weight-reducing property. The identification of both genetic and pharmacological implications on the prevention and management of BC is the ultimate aim of these studies.

Topics

No keywords indexed for this article. Browse by subject →

References

129

[1]

World Cancer Research Fund/American Institute for Cancer Research (2007)

[2]

Key "Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women" J Natl Cancer Inst (2003) 10.1093/jnci/djg022

[3]

Reeves "Cancer incidence and mortality in relation to body mass index in the Million Women Study: Cohort study" BMJ (2007) 10.1136/bmj.39367.495995.ae

[4]

Renehan "Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies" Lancet (2008) 10.1016/s0140-6736(08)60269-x

[5]

Vainio (2002)

[6]

John "Body size, modifying factors, and postmenopausal breast cancer risk in a multiethnic population: The San Francisco Bay Area breast cancer study" Springerplus (2013) 10.1186/2193-1801-2-239

[7]

Cheraghi "Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: A meta-analysis" PLoS One (2012) 10.1371/journal.pone.0051446

[8]

Bhaskaran "Body-mass index and risk of 22 specific cancers: A population-based cohort study of 5·24 million UK adults" Lancet (2014) 10.1016/s0140-6736(14)60892-8

[9]

Daling "Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma" Cancer (2001) 10.1002/1097-0142(20010815)92:4<720::aid-cncr1375>3.0.co;2-t

[10]

Olivotto "Prediction of axillary lymph node involvement of women with invasive breast carcinoma: A multivariate analysis" Cancer (1998) 10.1002/(sici)1097-0142(19980901)83:5<948::aid-cncr21>3.0.co;2-u

[11]

Ewertz "Effect of obesity on prognosis after early-stage breast cancer" J Clin Oncol (2011) 10.1200/jco.2010.29.7614

[12]

Berclaz "Body mass index as a prognostic feature in operable breast cancer: The International Breast Cancer Study Group experience" Ann Oncol (2004) 10.1093/annonc/mdh222

[13]

Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies

D.S.M. Chan, A.R. Vieira, D. Aune et al.

Annals of Oncology 2014 10.1093/annonc/mdu042

[14]

Krishnan "Associations between weight in early adulthood, change in weight, and breast cancer risk in postmenopausal women" Cancer Epidemiol Biomarkers Prev (2013) 10.1158/1055-9965.epi-13-0136

[15]

Lukanova "Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: A cross-sectional study in healthy women" Eur J Endocrinol (2004) 10.1530/eje.0.1500161

[16]

Rose "Biochemical and molecular mechanisms for the association between obesity, chronic inflammation, and breast cancer" Biofactors (2014) 10.1002/biof.1109

[17]

mTOR Signaling in Growth Control and Disease

Mathieu Laplante, David M. Sabatini

Cell 2012 10.1016/j.cell.2012.03.017

[18]

Xu "Association of TNF-α, TNFRSF1A and TNFRSF1B gene polymorphisms with the risk of sporadic breast cancer in northeast Chinese Han women" PLoS One (2014) 10.1371/journal.pone.0101138

[19]

Joshi "Interleukin 6 −174G>C polymorphism and cancer risk: Meta-analysis reveals a site dependent differential influence in ancestral North Indians" Hum Immunol (2014) 10.1016/j.humimm.2014.06.018

[20]

Kirschner "Obesity, androgens, estrogens, and cancer risk" Cancer Res (1982)

[21]

Simpson "Obesity and breast cancer: Role of inflammation and aromatase" J Mol Endocrinol (2013) 10.1530/jme-13-0217

[22]

Morris "Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer" Cancer Prev Res (Phila) (2011) 10.1158/1940-6207.capr-11-0110

[23]

Kern "Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance" Am J Physiol Endocrinol Metab (2001) 10.1152/ajpendo.2001.280.5.e745

[24]

Skurk "Relationship between adipocyte size and adipokine expression and secretion" J Clin Endocrinol Metab (2007) 10.1210/jc.2006-1055

[25]

Bulun "A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription" J Clin Endocrinol Metab (1993)

[26]

Chen "JunD and JunB integrate prostaglandin E2 activation of breast cancer-associated proximal aromatase promoters" Mol Endocrinol (2011) 10.1210/me.2010-0368

[27]

Meng "Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: Mechanism of desmoplastic reaction" Cancer Res (2001)

[28]

Zhou "Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: An epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta" Cancer Res (2001)

[29]

Mawson "Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1" Mol Cell Endocrinol (2005) 10.1016/j.mce.2004.08.002

[30]

Lee "Enhancement of insulin-like growth factor signaling in human breast cancer: Estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo" Mol Endocrinol (1999) 10.1210/mend.13.5.0274

[31]

Caldon "Estrogen signaling and the DNA damage response in hormone dependent breast cancers" Front Oncol (2014) 10.3389/fonc.2014.00106

[32]

De Pergola "Obesity as a major risk factor for cancer" J Obes (2013) 10.1155/2013/291546

[33]

Gunter "Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women" J Natl Cancer Inst (2009) 10.1093/jnci/djn415

[34]

Renehan "Obesity and cancer risk: The role of the insulin-IGF axis" Trends Endocrinol Metab (2006) 10.1016/j.tem.2006.08.006

[35]

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

Eugenia E. Calle, Rudolf Kaaks

Nature Reviews Cancer 2004 10.1038/nrc1408

[36]

Frasca "The role of insulin receptors and IGF-I receptors in cancer and other diseases" Arch Physiol Biochem (2008) 10.1080/13813450801969715

[37]

Frasca "Insulin and hybrid insulin/IGF receptors are major regulators of breast cancer cells" Breast Dis (2003) 10.3233/bd-2003-17108

[38]

Gallagher "The proliferating role of insulin and insulin-like growth factors in cancer" Trends Endocrinol Metab (2010) 10.1016/j.tem.2010.06.007

[39]

Novosyadlyy "Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes" Cancer Res (2010) 10.1158/0008-5472.can-09-2141

[40]

Magnuson "Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks" Biochem J (2012) 10.1042/bj20110892

[41]

Zhou "Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers" Clin Cancer Res (2004) 10.1158/1078-0432.ccr-04-0112

[42]

Bose "The Akt pathway in human breast cancer: A tissue-array-based analysis" Mod Pathol (2006) 10.1038/modpathol.3800525

[43]

Bostner "Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit" Breast Cancer Res Treat (2013) 10.1007/s10549-012-2376-y

[44]

García-Jiménez "A new link between diabetes and cancer: Enhanced WNT/β-catenin signaling by high glucose" J Mol Endocrinol (2014) 10.1530/jme-13-0152

[45]

Wnt/β-Catenin Signaling and Disease

Hans Clevers, Roel NUSSE

Cell 2012 10.1016/j.cell.2012.05.012

[46]

Naidu "Genetic variations in transcription factor 7-like 2 (TCF7L2) gene: Association of TCF7L2 rs12255372(G/T) or rs7903146(C/T) with breast cancer risk and clinico-pathological parameters" Med Oncol (2012) 10.1007/s12032-011-9837-8

[47]

Vona-Davis "Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression" Endocr Relat Cancer (2007) 10.1677/erc-06-0068

[48]

Guo "Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells" Biochim Biophys Acta (2012)

[49]

Dalamaga "Obesity, insulin resistance, adipocytokines and breast cancer: New biomarkers and attractive therapeutic targets" World J Exp Med (2013) 10.5493/wjem.v3.i3.34

[50]

Yin "Molecular mechanisms involved in the growth stimulation of breast cancer cells by leptin" Cancer Res (2004) 10.1158/0008-5472.can-04-0655

Showing 50 of 129 references

Metrics

90

Citations

129

References

Details

Published: Feb 10, 2016
Vol/Issue: 21(4)
Pages: 404-417
License: View

Authors

V

Valeria Simone